https://www.selleckchem.com/pr....oducts/pf-477736.htm
75% of patients were prescribed continuous subcutaneous infusion for symptom control, which was effective in 78.6% of patients. Compared to a 'typical' caseload, the COVID-19 cohort were on caseload for less time (median 2 vs 5 days; 0.001) and had a higher death rate (80.6% vs 30.3%; 0.001). The COVID-19 cohort replaced 'typical' caseload; overall numbers of referrals were not increased. Hospitalised COVID-19 positive patients referred for Palliative Care may have a short prognosis, differ from 'typical' caseload, and pre
Like
Comment
Share
